Given that there were fewer cases in the neoadjuvant chemotherapy group, the subgroup analyses (menopausal status, tumor size, N status, clinical stage, ER status, PR status, HER2 status, and Ki-67 expression level) could not be performed. Here, MKI67 is linked to neoplasm.